Cheryl Cohen Immunity Bio, Inc. (IBRX) insider trading activity
Cheryl Cohen is Director of ImmunityBio, Inc.. Currently has a direct ownership of 200,617 shares of IBRX, which is worth approximately $1.06 Million. The most recent transaction as insider was on Aug 23, 2021, when has been sold 14,801 shares (Common Stock) at a price of $10.12 per share, resulting in proceeds of $149,786. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
201K
0%
3M change
0%
12M change
Total Value Held
$1.06 Million
Cheryl Cohen Transaction History
Also insider at
CC
Cheryl Cohen
Director
San Diego, CA